Skip to main content

Why does Zeposia (ozanimod) slow down your heart rate?

Medically reviewed by Carmen Pope, BPharm. Last updated on May 24, 2024.

Official answer

by drugclasses.com

The reason ozanimod (Zeposia) may slow down your heart rate temporarily when you first start taking it is thought to be due to the action of ozanimod binding to one of the S1P receptors' subunits, S1P1R, which also has an effect of potassium channels in cardiac muscle cells. This reduces how responsive the cardiac cells are and reduces their firing rate, which slows down the heart.

How does ozanimod affect your heart rate?

The reason a decrease in heart rate is seen with the very first dose of ozanimod is thought to be due to the presence of S1P receptors on cardiac muscle cells. So, in addition to binding to lymphocyte S1P receptors, ozanimod also influences cardiac muscle cell S1P receptors which activate inward potassium channels, reducing the excitability of muscle cells and decreasing how frequently they fire. This has the effect of slowing down the heart rate.

The reason this only happens temporarily – usually only with the first dose of ozanimod and then not again – is thought to be explained by the cardiac muscle cell receptors becoming desensitized to ozanimod or internalization or degradation or the S1P receptor, meaning it no longer responds.

Many people experience transient decreases in heart rate when starting ozanimod. The incidence of this can be reduced by using a starting dose of 0.23mg ozanimod and increasing the dosage slowly over a week to the required maintenance dose.

References

Read next

Is Zeposia (ozanimod) a biologic? How does it work?

Zeposia (ozanimod) is a not a biologic it is a small-molecule S1P receptor modulator that binds specifically to two S1P receptors and is thought to block the ability of lymphocytes to escape out of the lymph nodes reducing their numbers in the blood, gut, CNS, and inflamed tissue. Continue reading

How long does it take Zeposia (ozanimod) to work?

Ozanimod (Zeposia) works quickly in people with MS, within a few months, although it may take up to a year for the full effects of significantly less disease progression, fewer relapses, and less brain atrophy than standard care to be seen. For people with UC, improvements in symptoms such as rectal bleeding and stool frequency were seen as early as week 2 and significant differences in clinical remission, clinical response, and endoscopic improvement compared to placebo were noted within 10 weeks of starting ozanimod. Continue reading

How long can you live with multiple sclerosis?

Multiple sclerosis (MS) is not generally considered life-threatening and most people will live a normal life-span. One study has found that the average life expectancy for people with MS is 76 years of age. In 2019, the U.S. life-expectancy averaged 78.8 years, but in 2020 it declined to 77.3 years, primarily due to the COVID pandemic. Many people with MS may live for 25 to 35 years or longer after their diagnosis. Continue reading

Related medical questions

Drug information

Related support groups